Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions to force lower prices.

Stocks edged up in Asia on Wednesday while the dollar wobbled as relatively benign U.S. inflation data fed into prospects of ...

Friedrich Merz becomes Chancellor of Germany amid economic challenges and trade tensions with the U.S., impacting EU ...

America’s largest airline is expanding its business class in an aggressive push to win market share from Qantas amid a ...

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...

WASHINGTON (AP) — Defense Secretary Pete Hegseth’s plans to slash the number of senior military leaders across the services ...

Visa crackdowns and political rhetoric are making foreign students feel increasingly unwelcome, which can have major ...

The Chairperson of Biocon Group said that generics and biosimilars are clearly part of the Affordable Care Act, but they are not the target of President Trump's current efforts.

# “People might want to sell directly into The Bahamas, who could then export to the States. They buy produce directly from these producing nations, rather than going by America. And, of course, if ...

I rate Halliburton as a Hold with a $21 price target based on a 2025 adjusted EPS of $2.33, reflecting bearish oil price ...

The domestic generic drugmakers are unlikely to be impacted by the US announcement of a 30-day deadline for companies to ...